Clinical Trials Browser

Phase 1/2 × Recruiting × abiraterone × Clear all

Neoplasm Metastasis, Prostatic Neoplasms, Castration-Resistant

NCT07190300 2026-05-12

TulmiSTAR-02

Phase 1/2 Recruiting

181 enrolled

Bulbo-Spinal Atrophy, X-Linked

NCT07226986 2026-05-11

A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC

Phase 1/2 Recruiting

123 enrolled

Genitourinary

PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy

NCT05914116 2025-11-21

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Phase 1/2 Recruiting

862 enrolled

DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Carcinoma, Hepatocellular, Melanoma, Prostatic Neoplasms, Small Cell Lung Carcinoma

Clinical Trials

IDeate-Prostate02

TulmiSTAR-02

A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors